Acute myeloid leukaemia: expression of MYC protein and its association with cytogenetic risk profile and overall survival.


Acute myeloid leukaemia (AML) is a clinically aggressive disease with marked genetic heterogeneity. Cytogenetic abnormalities provide the basis for risk stratification into clinically favourable, intermediate, and unfavourable groups. There are additional genetic mutations, which further influence the prognosis of patients with AML. Most of these result in… (More)
DOI: 10.1002/hon.2279


  • Presentations referencing similar topics